The polarization of axon and dendrites underlies the ability of neurons to integrate and transmit information in the brain. We show here that the serine/threonine kinase LKB1, previously implicated in the establishment of epithelial polarity and control of cell growth, is required for axon specification during neuronal polarization in the mammalian cerebral cortex. LKB1 polarizing activity requires its association with the pseudokinase Strada and phosphorylation by kinases such as PKA and p90RSK, which transduce neurite outgrowth-promoting cues. Once activated, LKB1 phosphorylates and thereby activates SAD-A and SAD-B kinases, which are also required for neuronal polarization in the cerebral cortex. SAD kinases, in turn, phosphorylate effectors such as microtubuleassociated proteins that implement polarization. Thus, we provide evidence in vivo and in vitro for a multikinase pathway that links extracellular signals to the intracellular machinery required for axon specification.
INTRODUCTION
Polarization lies at the heart of several aspects of neural development. As the brain forms, cortical neurons born at the apical ventricular zone undergo a vectorial migration toward the basal pia, where they form and populate specific layers. Then, as neurons extend neurites, one differentiates to become an axon and the others acquire distinct molecular, histological and electrophysiological properties to become dendrites. This cellular polarization underlies directional flow of information within neurons, from dendrites to soma to axon. Finally, processes contact each other and form synapses, which are asymmetric, polarized junctions in which the presynaptic terminal is specialized to release neurotransmitter and the postsynaptic membrane is specialized to respond to it. Accordingly, major questions in developmental neuroscience are how neuron polarization is initiated and implemented Wiggin et al., 2005) . The earliest aspect of neuronal polarization (the specification and differentiation of axons and dendrites) has so far been studied most extensively in cultured rodent hippocampal and cortical neurons. In the past few years, these studies have implicated numerous proteins in the establishment of neuronal polarity including multiple kinases, phosphatases, small GTPases, microtubule-associated proteins, and scaffolding proteins (Chen et al., 2006; Da Silva et al., 2005; Inagaki et al., 2001; Jiang et al., 2005; Menager et al., 2004; Schwamborn and Puschel, 2004; Shi et al., 2003 Shi et al., , 2004 Yoshimura et al., 2005 Yoshimura et al., , 2006 Yu et al., 2000) . It seems likely that among these proteins are critical determinants of polarization as well as factors that modulate cellular differentiation in diverse tissues, epochs of development, and contexts. Current challenges include determining which of these proteins play major roles in vivo and how they link extracellular determinants of polarity to intracellular responses.
Here, we address these issues with respect to a serine/ threonine kinase, LKB1 (also known as STK11). We focused on this enzyme for three reasons. First, LKB1 is a critical regulator of cellular polarity in nonneural tissues of vertebrates, insects and nematodes (Baas et al., 2004; Martin and St Johnston, 2003; Watts et al., 2000 ; reviewed by Alessi et al., 2006) . Second, the C. elegans ortholog of LKB1, Par4, is one of a group of six genes identified in a screen for determinants of early embryonic polarity (Kemphues et al., 1988) and later implicated in multiple other aspects of polarization. Recently, vertebrate orthologs of Par1, Par3 and Par6 have been shown to regulate polarization of rodent neurons in vitro (Chen et al., 2006; Shi et al., 2003) . Third, LKB1 is capable of phosphorylating and activating a set of at least 14 serine/ threonine kinases related to Par1 (Lizcano et al., 2004) ; these include the kinases SAD-A and SAD-B (also called Brsk2 and Brsk1), orthologs of a C. elegans gene implicated in synapse formation and neuronal polarity (Crump et al., 2001; Hung et al., 2007) . SAD kinases are the only vertebrate proteins shown to date to be required for neuronal polarization in vivo (Kishi et al., 2005) . Based on these results, we hypothesized that LKB1 might regulate the polarization of neurons, and might do so by activating SAD kinases.
Here, we show that LKB1 is required for axon initiation during neuronal polarization in the embryonic cortex in vivo and in vitro. The polarizing activity of LKB1 is enhanced by phosphorylation at a specific site, Serine 431 (S431), previously shown to regulate oocyte polarity in Drosophila (Martin and St Johnston, 2003) . This residue is the substrate for kinases such as protein kinase A (PKA) and p90 Ribosomal S6 Kinase (p90RSK), (Collins et al., 2000; Sapkota et al., 2001; Su et al., 1996) which mediate effects of extracellular cues that promote axon growth (Kao et al., 2002; Lebrand et al., 2004; Ming et al., 1997; Wong et al., 1996) . Once activated, LKB1 phosphorylates SAD-A and B, a modification required for activation of their catalytic activity. LKB1 is the major activator of SAD kinases in the developing cortex, and effects of LKB1 on neuronal polarity are mediated to a large extent by SAD kinases. Finally, activated SAD-A/B, but not LKB1, phosphorylates microtubule-associated proteins such as Tau that are involved in the growth and differentiation of axons and dendrites. Together with findings reported in a companion article (Shelly et al., 2007) , these results provide evidence for a pathway that links extracellular determinants of neuronal morphogenesis through a cascade of at least five kinases -TrkB, PKA, LKB1, SAD-A, and SAD-Bto cytoskeletal effectors that polarize neurons in vivo.
RESULTS

Neural Expression of LKB1 and Its Coactivators
To begin this study, we mapped expression of LKB1 in the developing nervous system. LKB1 was broadly expressed in the central nervous system (CNS) at E15.5, with highest levels in the forebrain (Figures S1A and S1B in the Supplemental Data available with this article online). It was also expressed by peripheral nervous structures such as dorsal root ganglia ( Figure S1C ). Within the forebrain, LKB1 mRNA was present both in the ventricular zone (VZ), which contains neural progenitors, and in the cortical plate (CP), which contains postmitotic neurons ( Figure 1A ). Expression was maintained through embryogenesis and postnatal life (Figures S1E and S1F).
LKB1 is active only when complexed with a pseudokinase protein called STRAD, and an armadillo-like protein called MO25 (Boudeau et al., 2003) . The mouse genome contains two Strad genes, (Strada and Stradb) as well as two MO25 genes (MO25a and MO25b). At E15.5, Strada is expressed relatively uniformly throughout the forebrain, but Stradb and MO25a are selectively expressed in the CP (Figures 1B-1D) . Thus, LKB1 might be differentially activated in postmitotic neurons and dividing progenitors. Like LKB1, expression of Strada, Stradb and MO25a in the cortex is maintained throughout embryogenesis and postnatal life (Figures S1D and S1G-S1L).
We next assessed the distribution of LKB1 protein in the developing cortex. At E15.5, LKB1 was found in the VZ and the CP (Figures 1E and 1I ). Ventricular labeling was associated with nestin-positive radial glia and neural progenitors ( Figures 1E-1H ). LKB1 in the CP and the marginal zone (MZ) was present in postmitotic neurons, as shown by double-labeling with an antibody to the neuron-specific MAP2(a-b) isoforms ( Figures 1I-1L ). From E15.5 until birth, LKB1 was enriched in the nucleus of neurons in the deepest portion of the CP ( Figures 1E, 1M , 1Q, and 1R) suggesting a progressive nuclear enrichment in the most differentiated neurons.
Within cortical neurons, LKB1 was concentrated in nuclei, but also present at low levels in axons, as shown by coincidence with the corticofugal axon marker, TAG1 ( Figures 1M-1P) ; (Kawano et al., 1999) . To more clearly visualize neuritic LKB1, we dissociated E14.5 cortical progenitors, cultured them for 7 days, then stained with the axonal marker, Tau-1 and the dendritic marker, MAP2. In vitro as in vivo, LKB1 was enriched in the nucleus, as previously shown in nonneuronal cells (Baas et al., 2003) , but was also present in neurites. Immunoreactivity was present in both axons and dendrites ( Figures 1S-1V ). Because levels of immunoreactivity were low, we also coexpressed an LKB1-EGFP fusion and a cytoplasmic red fluorescent protein (tdTomato) in cortical progenitors which confirmed that LKB1 is concentrated in nuclei but also present in both axons and dendrites ( Figures 1W-1Y ).
LKB1 Is Necessary for Axon Formation in Cortical Neurons In Vivo
Mice lacking LKB1 die between E8 and E11, before the cerebral cortex forms, reflecting roles of LKB1 in mesenchymal and vascular development (Jishage et al., 2002; Miyoshi et al., 2002; Ylikorkala et al., 2001) . To assess the roles of LKB1 in cortical development, we used a conditional allele (LKB1 F ), which generates a null allele upon Cre-mediated recombination (Bardeesy et al., 2002) . We limited LKB1 inactivation to dorsal telencephalic progenitors by using the Emx1
Cre transgenic mice (Gorski et al., 2002) which drives efficient recombination in progenitors of at least 95% of all pyramidal neurons in the cerebral cortex (Bareyre et al., 2005; Gorski et al., 2002) . Loss of LKB1 from Emx1
Cre/+ ;LKB1 F/F cortex was confirmed by immunostaining and immunoblotting ( Figure S2 ). Residual LKB1 expression may reflect its presence in nonpyramidal interneurons, which do not express Emx1 (Gorski et al., 2002) .
The cortex was roughly normal in size and shape in Emx1
Cre/+ ;LKB1 F/F mice, but had a thinner cortical wall and larger lateral ventricles than in controls (Figures 2A-2D ). Cortical thinning reflected, in part, death of postmitotic neurons, as shown by double-labeling with anti-activated caspase 3 and the neuronal marker anti-b-tubulin III ( Figure S3 ). In contrast, labeling with the mitotic marker anti-phospho-Histone H3 provided no evidence for strong defects in neurogenesis ( Figure S4 ). We used a panel of markers to assess the cytoarchitecture of mutant cortex, including nuclear (Draq 5) and cytoplasmic dyes (Neurotrace), general neuronal markers (NeuN and b-tubulin III), a dendritic marker [MAP2(a-b)], and layer-specific neuronal markers for layer 1 (reelin and Tbr1; [Hevner et al., 2001; Ogawa et al., 1995] ), layer 2-4 (Cux1; [Nieto et al., 2004] ) and layer 6 neurons (Tbr1; [Hevner et al., 2001] ). This analysis revealed subtle defects in formation of discrete laminae, confinement of specific cell types to appropriate layers, and radial orientation of dendrites ( Figures  2E-2N) . Nonetheless, by all these criteria, cytoarchitecture was largely preserved in the absence of LKB1, suggesting that it is dispensable for proper radial migration and lamination during cortical development.
In contrast, staining with axonal markers revealed a dramatic defect in Emx1
Cre/+ ;LKB1 F/F cortex. In control embryos, corticofugal axons, selectively labeled with antibodies to TAG-1 (Kawano et al., 1999) , grow laterally toward the internal capsule, en route to subcortical target structures (arrows in Figure 2A ). In contrast, few TAG1-positive axons were observed in Emx1
Cre/+ ;LKB1 F/F embryos ( Figure 2B ). Similarly, callosal axons labeled with antibodies to L1 were nearly absent from Emx1
Cre/+ ; LKB1 F/F cortex, resulting in agenesis of the corpus callosum ( Figures 2C and 2D ). Labeling with a general axonal marker, NF165 kDa, confirmed the drastic reduction of cortical axons in the absence of LKB1 expression, both at E15.5 and at birth ( Figures 2C and 2D and data not shown).
The lack of axons in Emx1
Cre/+ ;LKB1 F/F cortex could result from an early failure to initiate axon growth, impairment of axon elongation, or degeneration following initial extension. To distinguish these possibilities, we examined the morphology of individual neurons during radial migration. Recent studies have shown that many cortical neurons initiate axon outgrowth during radial migration, before they reach the CP (Hatanaka and Murakami, 2002; Noctor et al., 2004) . Cells were labeled by electroporation of EGFP ex vivo at E14.5 ( Figure 3A) ; this method selectively marks nestin-positive radial glial progenitors in the VZ, which predominantly give rise to layer 5 pyramidal neurons at this stage (Angevine and Sidman, 1961; Hand et al., 2005; Polleux et al., 1997) . Following electroporation, the cortices were maintained as organotypic slice cultures for 3 to 5 days then imaged using confocal microscopy. After 3 days in vitro, many electroporated neurons in both control and mutant slices had migrated through the IZ and reached the CP ( Figures 3B and 3C ), confirming that LKB1 is dispensable for proper radial migration. In control slices, most labeled neurons in the IZ (43/52 or 82.7%) and all of those that had reached the CP (34/34) had extended a single >100 microns long axon (Figures 3D and 3F) . In contrast few of the labeled neurons in the IZ (5/57 or 8.8%; p < 0.001 compared to control) or CP (3/41 or 7.3% p < 0.001 compared to control) of Emx1 Cre/+ ; LKB1 F/F slices had a >100 mm long axon . Even after five days in vitro, when numerous EGFP-labeled axons had grown toward the midline or internal capsule in control slices, only few labeled axons were present in mutant cultures ( Figures  3J-3M ). Thus, LKB1 is required for axon initiation when neurons engage radial migration through the intermediate zone.
Because the electroporation method only labels a subpopulation of layer 5 neurons, we microinjected Biotinylated Dextran Amine (BDA) into neonatal cortex which provides full anterograde tracing of cortical axons throughout cortical layers (Chang et al., 2000) . In control mice, BDA-labeled corticofugal axons projected to the internal capsule (double arrows in Figure 3N ) and toward the corpus callosum (arrow in Figure 3N ). Similar injections in the cortex of Emx1
Cre/+ ;LKB1 F/F mice labeled neuronal somata, but fail to label substantial numbers of efferent axons ( Figure 3O ). A few single axons were occasionally found deep in the cortical wall close to the ventricle ( Figure 3P ). Altogether these results show that LKB1 expression is required for axon extension by cortical neurons in vivo.
Cell-Autonomous Role of LKB1 in Axon Specification
For detailed analysis of neuronal differentiation in the absence of LKB1, we marked cortical progenitors at E14.5 by ex vivo electroporation as described above ( Figure 3A ), then dissociated the cortices and cultured the cells. In this method, electroporated progenitors are cultured before they have undergone any overt polarization or differentiation (Hand et al., 2005 ; and data not shown). Most EGFP-labeled neurons differentiating in control or mutant cultures extended multiple processes (Figures 4A and 4B) . In control cultures, the longest process was Tau1-positive but MAP2-negative, marking it as an axon (double arrows in Figures 4A and 4G-4J), whereas the shorter processes were MAP2-positive but Tau1-negative, marking them as dendrites (arrowhead in Figures 4A and 4C-4F). In contrast, EGFP-labeled cortical mutant neurons failed to polarize properly. Neurites were relatively uniform in length ( Figure 4B ), and contained both MAP2 and Tau-1 ( Figures 4K-4N ). Nearly all (98%) of control neurons but only 30% of mutant neurons bore an axon as defined by being more than 100 microns long, Tau-1-positive, and MAP2-negative ( Figure 4O ). Moreover, the average length of the longest neurite in LKB1 mutant neurons was about one-fourth that in control neurons, and therefore intermediate between that of axons and dendrites in control neurons ( Figure 4P ). Taken together, these results show that LKB1 is required for neuronal polarization of cortical neurons. Results presented so far do not allow us to distinguish whether LKB1 is part of the cellular machinery required for neuronal polarization to occur, or whether it plays a critical regulatory role in this process. To address this issue, we performed a gain-of-function experiment. We used ex vivo electroporation to overexpress LKB1 and/or Strada in wild-type neurons. Coexpression of LKB1 and Strada in E14.5 progenitors led to extension of multiple, long, Tau-1-positive axons from over half of the neurons examined ( Figures 4Q-4X and 4Y ). This result demonstrates a cell-autonomous and instructive role for LKB1 in axon specification. In contrast, overexpression of either LKB1 or Strada had no significant effect on the number of Tau1-positive axons emerging from the cell body of cortical neurons ( Figure S5 and Figure 4Y ). This result suggests that endogenous LKB1 and Strada are both present in limiting amounts in cortical neurons.
LKB1 Phosphorylation Is Required for LKB1-Dependent Neuronal Polarization
Although LKB1 is present in all neurites of cortical neurons (Figure 1 ), it appears to play a dominant role in specification of axons but not dendrites, raising the possibility that its activity is spatially regulated within neurons. One modification of LKB1 that regulates its function is phosphorylation at a conserved serine residue, S431 (Martin and St Johnston, 2003; Sapkota et al., 2001 ). Both PKA and p90RSK can phosphorylate LKB1 at this site (Sapkota et al., 2001) . We examined phosphorylation of LKB1 at S431 in developing neurons, by using a phospho-specific antibody. Specificity of the anti-pLKB1 (S431) antibody was demonstrated by showing that it failed to stain cortical neurons isolated from Emx1
Cre/+ ; LKB1 F/F mice ( Figure S6 ). Immunoblotting showed that pLKB1 (S431) was present in the cortex at E15.5 and increased approximately 4-fold between E15.5 and P1, the interval during which newly-generated neurons extend axons ( Figures  5N and 5O ). We then used this antibody to stain neurons dissociated and cultured from E15.5 cortex. We categorized neurons by the criteria proposed by Dotti et al. (1988) for cultured hippocampal neurons: Stage 2 neurons have multiple neurites but are unpolarized, whereas by Stage 3, one neurite has become substantially longer than the others, and begun to acquire axonal characteristics. pLKB1 (S431) was present at low levels in all neurites of Stage 2 neurons but became concentrated in the axon of Stage 3 neurons ( Figures 5A-5F ). Because total LKB1 was present at similar levels in all neurites at this stage ( Figures 1S-1Y ), this result suggests preferential phosphorylation and/or deficient dephosphorylation of LKB1 at S431 in axons.
To ask whether phosphorylation of LKB1 at S431 affects its ability to promote axon formation, we tested a mutant in which S431 was mutated to alanine (LKB1 S431A and Strada by ex vivo electroporation was significantly less effective in promoting formation of supernumerary axons than was coexpression of wild-type LKB1 and Strada) ( Figure 5M ).
LKB1 Polarizes Neurons by Activating SAD-A/B Kinases
What are the critical substrates of LKB1 mediating its function during axon specification? Two observations suggested that they might include SAD kinases. First, the cortical phenotypes of Emx1
Cre/+ ;LKB1 F/F mutants resemble those of SAD-A; SAD-B double mutant mice, both in vivo and in vitro (Kishi et al., 2005) . Second, in a cell-free system, LKB1 has been shown to phosphorylate and activate several related kinases including the human orthologs of SAD-A and -B (Lizcano et al., 2004) . This residue is T175 in SAD-A and T187 in SAD-B, and the two kinases show 100% identity over a stretch of 27 residues flanking this phorphorylation site (Kishi et al., 2005) . To ask whether LKB1 phosphorylates SAD kinases in vivo, we generated and purified phospho-specific antibodies to the shared peptide centered around pT175/T187 of SAD-A and SAD-B, respectively. We refer to this phospho-specific antibody as pSAD (T-al), since it is directed to the phosphorylated Threonine residues of the activation loop of SAD-A and SAD-B. ELISA showed that the pSAD (T-al) antibody reacted >1000-fold more strongly with phosphorylated than nonphosphorylated peptide, and immunoblotting showed that it reacted well with both phospho-SAD-A and phospho-SAD-B, but not with SAD-A or -B mutants in which the activation loop threonine had been mutated to alanine (T175A or T187A; Figure 6A and data not shown).
To assay LKB1-dependent phosphorylation of SAD kinases, we used HeLa cells, because they express Strada and MO25a but not LKB1, SAD-A or SAD-B ( Figure 6A ) (Boudeau et al., 2003) . SAD-A was phosphorylated on T175 when coexpressed in HeLa cells with wildtype LKB1, but was not detectably phosphorylated on this residue when expressed alone or coexpressed with catalytically inactive LKB1 mutants (LKB1 D194A or LKB1 K78I ; Figure 6A and Figure S7A ). Similar results
were obtained with SAD-B (data not shown). These results show that LKB1 can phosphorylate SAD kinases. To ask whether this phosphorylation is required for SAD kinase activity, we made use of our previous observation that SAD kinases phosphorylate the microtubule-associated protein Tau at S262 (Kishi et al., 2005) . This result was obtained in cell lines that expressed LKB1. In contrast, when we coexpressed SAD-A and Tau in HeLa cells, then probed lysates with a phospho-specific antibody to pTau (S262), no phosphorylation was detectable. Coexpression of LKB1, however, resulted in robust tau phosphorylation ( Figure 6A ). Tau phosphorylation resulted from LKB1-dependent phosphorylation of SAD-A rather than a direct effect of LKB1 because no phosphorylation was observed when SAD-A was omitted or mutated to a form that cannot be phosphorylated by LKB1 (SAD-A T175A ; Figure 6A and Figure S7B ). Thus, LKB1 is an activator of SAD kinases.
To determine whether LKB1 is the endogenous activator of SAD kinases in the developing cortex, we probed lysates from control and Emx1
Cre/+ ;LKB1 F/F cortex with anti-SAD-A, anti-SAD-B, and the pSAD (T-al) antibody. Levels of SAD-A and SAD-B showed no major or consistent difference between mutants and controls (n = 8), but levels of pSAD (T-al) were dramatically decreased in the mutant cortex ( Figure 6B ). As noted above, low levels of LKB1 persist in the mutants ( Figure S2G ), and may account for the residual pSAD (T-al). We cannot, however, rule out the possibility that other kinases in cortex are capable of phosphorylating SAD kinases. Nonetheless, these results demonstrate that LKB1 is the major activator of SAD kinases in neonatal cortex. LKB1 can phosphorylate the activation loop of 14 related kinases in nonneural cells but many of these can be phosphorylated and activated by other kinases as well (Alessi et al., 2006) . Is LKB1 the major activator of all of these kinases in brain? To test this possibility, we used a phospho-specific antibody to the activation loop of AMP-activated kinase, pAMPK (T172), which is activated by LKB1 in muscle and liver (Sakamoto et al., 2005; Shaw et al., 2005) . In cortex, in contrast, levels of pAMPK (T172) were not detectably affected by loss of LKB1 ( Figure 6B ). This result emphasizes the selective association of LKB1 and SAD kinases in the developing brain.
We also used pSAD (T-al) antibodies to localize phosphorylated SAD kinases in the brain. Whereas SAD kinases are present throughout the cortex in both dendrites and axons of cortical neurons (Kishi et al., 2005) , pSAD (T-al) is concentrated in cortical axons at E15.5 ( Figure S8 ). Staining is nearly absent from
Emx1
Cre/+ ;LKB1 F/F cortex, reflecting both lack of SAD activation and loss of axons ( Figures 6C-6F) . Likewise, levels of pTau (S262), which are greatly decreased in SAD-A/B mutant brain (Kishi et al., 2005) , are decreased in Emx1Cre/+;LKB1 F/F cortex (data not shown). Taken together, these results suggest that LKB1 function in cortical development depends on its ability to activate SAD kinases. To further test this idea, we designed short hairpin RNAs that selectively and efficiently knock down SAD-A and SAD-B protein levels in heterologous cells ( Figure 6G ). We expressed these shRNAs along with LKB1 and Strada in dissociated cortical neurons using the ex vivo electroporation method described above. The ability of overexpressed LKB1 and Strada to induce supernumerary axons was unaffected by control shRNA ( Figures 6H-6J'' ; compare to Figure 5P ), but was decreased 2-fold by a combination of shRNAs targeting SAD-A and SAD-B ( Figures 6K and 6L '' and 6M). We conclude that SAD-A/B kinases act downstream of LKB1 to promote axon specification during neuronal polarization.
DISCUSSION
A Kinase Pathway Required for Cortical Neuron Polarization LKB1 is a tumor-suppressor mutated in more than 80% of patients presenting the cancer predisposition syndrome called Peutz-Jeghers Syndrome (Alessi et al., 2006) . Activation of LKB1 is sufficient to polarize mammalian epithelial cells in the absence of cell-cell contact (Baas et al., 2004) . LKB1 is viewed as a master regulator of cell polarity because it is the only protein so far shown to have this activity. The C. elegans and Drosophila orthologs of LKB1 (Par4 and dLKB1, respectively) are also regulators of embryonic polarity, controlling anterior-posterior axis formation in both species and epithelial cell polarity in flies (Martin and St Johnston, 2003; Watts et al., 2000) . Previous studies had not examined the role of LKB1 or its orthologs in neuronal polarity. The severe and specific defects we documented in LKB1 conditional knockout mice demonstrate a unique and nonredundant role for LKB1 in polarization of cortical neurons. Several biological activities mediated by LKB1 require the phosphorylation of S431. For example, oocyte polarity defects seen in dLKB1 null mutant flies are effectively rescued by reintroduction of wild-type dLKB1 but not by dLKB1 bearing a single point mutation at the equivalent site (S535) (Martin and St Johnston, 2003) . We provide several lines of evidence suggesting that phosphorylation of this site is also important for neuronal polarization. This site is a substrate for PKA and p90RSK (Sapkota et al., 2001) , which are both activated in response to many extracellular cues in multiple cell types. Specifically, BDNF has been shown to induce phosphorylation of LKB1 on Serine 431 in a p90RSK-dependent manner (Arthur et al., 2004) . Moreover, Shelly et al. (2007) provide evidence that induction of axon differentiation by local presentation of brain-derived neurotrophic factor (BDNF) requires PKA-dependent LKB1 phosphorylation on S431. Taken together with our data, these results support the idea that LKB1 phosphorylation at this site serves as an intracellular sensor of extracellular polarizing signals in vivo (see Figure 7) .
In contrast to Shelly et al. (2007) , we did not observe asymmetric localization of total LKB1 protein in cultured cortical neurons. This difference might be due to the nature of the systems used. Our cultures consisted of electroporated cortical neuronal progenitors undergoing polarization for the first time in vitro, whereas, the hippocampal neurons cultured by Shelly et al. (2007) had already undergone polarization in vivo before dissociation. Most importantly, both studies provide strong evidence that local activation of LKB1 by phosphorylation on S431 is critical for axon specification.
How are effects of LKB1 on neuronal polarity mediated? Mice lacking LKB1 show defects in neuronal polarization similar to those demonstrated previously in SAD-A/B double mutants (Kishi et al., 2005) . Moreover, SAD-A and SAD-B are inactive both in cultured cells and in developing cortex in the absence of LKB1. Thus, LKB1 regulates cortical neuronal polarization at least in part by activating SAD-A and SAD-B.
SAD kinases phosphorylate the microtubule-associated protein Tau on S262 in a KXGS motif present in the tubulin binding domain (Kishi et al., 2005) . The KXGS motif is also found in other microtubule-associated proteins including MAP2, MAP4 and Doublecortin (Ebneth et al., 1999; Schaar et al., 2004) . SAD kinases appear likely to phosphorylate at least some of these proteins (B.N.L. and J.S. unpublished). Microtubule binding proteins such as Tau and doublecortin have been implicated in axon specification and neuronal polarization (Caceres and Kosik, 1990; Deuel et al., 2006; Kempf et al., 1996; Koizumi et al., 2006) . Thus, one way in which SAD kinases may affect neuronal polarization is by regulating cytoskeletal dynamics prior to or coincident with the specification of the axon. Current studies are aimed at identifying the preferred sites of SAD kinase phosphorylation and determining the identity of SAD kinase substrates involved in neuronal polarization.
Multiple Molecular Mechanisms Controlling Neuronal Polarity
Many signaling molecules have been implicated in polarization of cultured mammalian neurons. They include We propose that specific extracellular signals control axonal specification and polarization in cortical neurons by activating LKB1 and SAD kinases in the neurite becoming the axon. See Discussion for details.
glycogen synthase kinase 3b (GSK3b), phosphotidylinositol 3 0 (PI3) kinase, atypical protein kinase C (aPKC), protein kinase B (AKT), the phosphatase PTEN, the tubulin binding protein CRMP-2, the small GTPases Rac1 and cdc42, their regulators DOCK 7, Rap1b, and Tiam-1, and vertebrate orthologs of C. elegans Par1, Par3 and Par6 (Chen et al., 2006; Da Silva et al., 2005; Inagaki et al., 2001; Jiang et al., 2005; Menager et al., 2004; Schwamborn and Puschel, 2004; Shi et al., 2003 Shi et al., , 2004 Yoshimura et al., 2005 Yoshimura et al., , 2006 Yu et al., 2000) . These proteins may act in distinct neuronal populations or at distinct times of development. It is also possible, however, that several of these proteins interact with or function via the PKA/p90RSK-LKB1-SAD-A/B pathway that we have described.
Particularly interesting in this regard are the Par proteins (Par1-6) initially identified as regulators of embryonic polarity in nematodes (Kemphues et al., 1988) . As noted above, LKB1 is the vertebrate ortholog of Par-4 and SAD is related to Par-1. All of the C. elegans Par proteins act as parts of a single pathway, and there is increasing evidence that their vertebrate orthologs form complexes and act together (Wiggin et al., 2005) . Recently, a complex containing Par3 and Par6 has been implicated in control of hippocampal neuron polarity (Shi et al., 2003) . Other components of this complex include cdc42 and aPKC, both of which have also been shown to affect axon initiation in vitro (Chen et al., 2006; Schwamborn and Puschel, 2004) . A rodent ortholog of Par-1, MARK2, has also been implicated in neuronal polarization (Biernat et al., 2002; Chen et al., 2006) . In a model derived from studies of C. elegans embryos and mammalian epithelial cells, Par4/LKB1 phosphorylates Par-1/MARK, which phosphorylates Par-3 on two distincts Serine residues creating a binding site for Par-5/14-3-3, which modulates the activity of the Par3/Par6/aPKC complex (Benton and St Johnston, 2003) . In neurons, a similar cascade might be important for axon specification, with SAD-A/B acting along with or in place of MARKs (see Figure 7) . LKB1 has several substrates other than SAD-A/B and MARKs. Phosphorylation of one of them, AMPKa, is not affected in LKB1-deficient cortex at birth, but might be affected at later stages. LKB1 activates AMPK in muscle and liver, and conditional mutants lacking LKB1 in these organs exhibit altered metabolism and function (Sakamoto et al., 2005; Shaw et al., 2005) . Similarly, AMPK and other substrates of LKB1 might regulate functional properties of adult neurons. Interestingly, SAD-B has recently been implicated in synaptic function (Inoue et al., 2006) .
Neuronal Polarization In Vitro versus In Vivo
LKB1 can be phosphorylated on S431 in response to a polarized distribution of extracellular cues or spontaneously in the apparent absence of such cues. In the latter case, local anisotropies in the substrate might exist or small stochastic differences among neurites might be detected and amplified, leading to one neurite becoming an axon . Thus, axonal specification could result from either directed (in vivo) or stochastic (in vitro) local phosphorylation of LKB1 and subsequent local activation of SAD kinases (Figure 7) . Subsequently, either repression of S431 phosphorylation or active dephosphorylation by ubiquitous phosphatases might repress axonal differentiation or promote dendritic differentiation in other processes. Later still, LKB1 and/or SAD-A/B might be activated in dendrites; indeed, our previous study provided evidence for SAD-dependent changes in dendritic cytoskeleton (Kishi et al., 2005) .
In vivo, the initial step of axon/dendrite polarization most likely results from the ability of unpolarized neuron progenitors to polarize intracellular components in response to asymmetrically distributed extracellular cues. In the cerebral cortex, it is now clear that polarization occurs during radial migration, before neurons reach their final position in the CP. The leading process becomes the apical dendrite and the trailing process becomes the axon (Figure 7 ) (Hand et al., 2005; Hatanaka et al., 2004; Hatanaka and Murakami, 2002; Noctor et al., 2004; Sidman and Rakic, 1973; Solecki et al., 2004) . It is therefore important to identify such cues. In C.elegans, a local gradient of Netrin dictates the pole of the neuron from which an axon emerges (Adler et al., 2006) . In the developing mammalian cortex, a gradient of Semaphorin3A within the CP act as a chemorepulsive cue to bias polarized outgrowth of axons toward the intermediate zone (Polleux et al., 1998) . Such extracellular cues might locally activate the kinase signaling cascade identified in this study, regulating key cytoskeletal components and leading to polarized differentiation of axons and dendrites.
EXPERIMENTAL PROCEDURES
Animals
Mice were used according to protocols approved by the Institutional Animal Care and Use Committees at the University of North CarolinaChapel Hill and Harvard University, and in accordance with NIH guidelines. Time-pregnant females were maintained in a 12 hr light/dark cycle and obtained by overnight breeding with males of the same strain. Noon following breeding is considered as E0.5.
Histochemistry and In Situ Hybridization
In situ hybridization was carried out using digoxigenin-labeled riboprobes as described previously (Dufour et al., 2003) . Probes were generated from the following mouse cDNA clones purchased from Open Biosystems (Huntsville, AL): LKB1 (Genbank: BF233256, IMAGE: 4159322). Strad-a (BC058517, IMAGE:5717255). Strad-b (BI220161, IMAGE:5098489), IMAGE:6504639) .
Cultured neurons and brain sections were immunostained by previously described methods (Polleux and Ghosh, 2002) . The following antibodies were used: chicken anti-GFP (Upstate), mouse anti-Tuj1 (b-III tubulin) (Sigma), rabbit anti-pLKB1 (S431) antibodies (Cell Signaling, Santa Cruz), rabbit anti-Tbr1 (gift from Robert Hevner), anti-Cux1 (gift of Dr. Christopher Walsh, Harvard), rabbit anti-total-LKB1 (Upstate), mouse anti-nestin (BD Bioscience), mouse anti-neurofilament 165 (2H3, Developmental Studies Hybridoma Bank), rat anti-L1 (Chemicon), mouse anti-MAP2 (a/b isoforms) Clone AP20 (Sigma), mouse mAb anti-Tau-1 (Chemicon), rabbit anti-activated caspase 3 (Cell Signaling), rabbit anti-phospho-Histone H3 (Cell Signaling), mouse anti-TAG1 (4D7; Developmental Studies Hybridoma Bank), mouse anti-Reelin (Calbiochem), mouse anti-NeuN (Chemicon), Neurotrace fluorescent Nissl stain (Invitrogen) and the DNA labeling compound Draq5 (Axxora). All images were captured using a LEICA TCS SL confocal microscope.
Constructs
The LKB1-K78I mutant was generously provided by Dr. Lewis Cantley via the Addgene plasmid repository (Addgene plasmid 8591, http:// www.addgene.org). All cDNAs were subcloned into a pCIG2 vector (Hand et al., 2005) , which contains a (cDNA)-IRES-EGFP under the control of a CMV-enhancer/chicken b-actin promoter. tdTomato was expressed from the plasmid pCIT (gift of Dr. Tom Maynard; UNC Chapel Hill) which utilizes the tdTomato cDNA provided by Dr. Roger Tsien. miR-based shRNAs targeting the coding regions of SAD-A and -B were designed and inserted into vectors using procedures detailed in Supplementary Methods.
Electroporation and Primary Cultures
Mouse cortical progenitors were electroporated ex vivo at embryonic day (E) 14.5 and subsequently cultured as dissociated cells or slices as previously described (Hand et al., 2005; Polleux and Ghosh, 2002) (see Supplementary Methods for details).
Analysis of SAD-A/B Phosphorylation
To generate a pSAD (T-al) antibody, the peptide sequence N-KGDSLLE(pT)SCGSPHY-COOH was synthesized and conjugated to KLH for immunization of New Zealand white rabbits. Terminal bleeds were passed over a column containing the nonphosphorylated version of the immunogenic peptide followed by affinity purification using a column containing the phosphorylated peptide (Covance Research Products, Denver, PA). ELISA and immunoblotting confirmed that the purified antibody lacked reactivity toward the nonphosphorylated peptide as well as the nonphosphorylated SAD-A/B proteins. See Supplementary Methods for more details.
SDS-PAGE immunoblotting using the following antibodies: antiphospho-SAD-A/B (pSAD (T-al); 1:5000), anti-SAD-A (hybridoma supernatant 1:5), anti-SAD-B (crude serum 1:5000) (Kishi et al., 2005) , anti-LKB1 (1:1000, Upstate), anti-AMPK and anti-pAMPK (T172) (1:1000, Cell Signaling), anti-pTau (Ser262) and anti-Tau antibodies were from Stressgen (Ann Arbor, MI).
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